Clinical Development

© VeranoVerde / Getty Images

Exagen on why AVISE test can end the ‘diagnostic odyssey’

Autoimmune diagnostics life sciences company Exagen is heralding the completion of the CAPSTONE study as evidence that its AVISE Lupus test is more clinically effective than traditional ANA methods (tANA), benefiting patients, providers and payers by...

(Iuliia Kanivets/iStock via Getty Images Plus)

CVS Health agrees to acquire Signify Health

By Jenni Spinner

With the purchase, the company is looking to advance its plans to connect with potential trial participants and spread awareness of study participation.

(royyimzy/iStock via Getty Images Plus)

People on the Move: September 2022

By Jenni Spinner

This month’s announcements of appointments, acquisitions, new hires, and other news include Standigm, Astellas Pharma, Trialbee, and other key companies.

(jirawut seepukdee/iStock via Getty Images Plus)

Tech Innovations: August 2022

By Jenni Spinner

This month’s news on technology, partnerships, expansions, and more includes items from IQVIA, Almac Group, Signant Health, Lonza, and other key companies.

Follow us

Products

View more

Webinars